VK2735 for Weight Management Phase 3 (NCT07104500)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants Without Type 2 Diabetes Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition
🩺 Plain-English Summary (8th-Grade Level)
This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults who are obese (BMI ≥30 kg/m2) or overweight (BMI ≥27 kg/m2) with one or more weight related comorbid condition without Type 2 Diabetes.
Who can join: Review the eligibility criteria below.
Location: Viking Clinical Site #1037 — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (137 Sites)
Showing the first 25 of 137 sites.
- Viking Clinical Site #1037 — Birmingham, Alabama
- Viking Clinical Site #1064 — Birmingham, Alabama
- Viking Clinical Site #1128 — Huntsville, Alabama
- Viking Clinical Site #1081 — Mobile, Alabama
- Viking Clinical Site #1005 — Chandler, Arizona
- Viking Clinical Site #1017 — Flagstaff, Arizona
- Viking Clinical Site #1018 — Peoria, Arizona
- Viking Clinical Site #1135 — Scottsdale, Arizona
- Viking Clinical Site #1019 — Tucson, Arizona
- Viking Clinical Site #1036 — Little Rock, Arkansas
- Viking Clinical Site #1071 — Chula Vista, California
- Viking Clinical Site #1070 — Escondido, California
- Viking Clinical Site #1054 — Huntington Park, California
- Viking Clinical Site #1014 — Lake Forest, California
- Viking Clinical Site #1129 — Lemon Grove, California
- Viking Clinical Site #1051 — Lincoln, California
- Viking Clinical Site #1050 — Long Beach, California
- Viking Clinical Site #1055 — Los Angeles, California
- Viking Clinical Site #1078 — Manteca, California
- Viking Clinical Site #1053 — Montclair, California
- Viking Clinical Site #1068 — Panorama City, California
- Viking Clinical Site #1132 — Rolling Hills Estates, California
- Viking Clinical Site #1131 — San Diego, California
- Viking Clinical Site #1104 — Santa Maria, California
- Viking Clinical Site #1052 — Spring Valley, California
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Weight Loss
- VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) — Birmingham, Alabama
- Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) — Palo Alto, California
- Risk of Metabolic Adaptation After Weight Loss — Milwaukee, Wisconsin
- Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions — Baltimore, Maryland
- Choosing Healthy Activities and Lifestyle Management Through Portal Support — Memphis, Tennessee
- iAmHealthy Parents First: A Televideo Parent and Child Obesity Program for Rural Families — Kansas City, Kansas
Explore by condition: All Weight Loss clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.